Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis

OBJECTIVES--To determine if the presence of low percentages of CD8 positive cells or high levels of soluble interleukin-2 receptors (sIL-2R) define a subgroup of patients with more severe polymyalgia rheumatica and giant cell arteritis (PMR/GCA). METHODS--38 PMR/GCA patients were followed up prospec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of the rheumatic diseases 1995-08, Vol.54 (8), p.640-644
Hauptverfasser:	Salvarani, C, Boiardi, L, Macchioni, P, Rossi, F, Tartoni, P, Casadei Maldini, M, Mancini, R, Beltrandi, E, Portioli, I
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over AIDS/HIV Anti-Inflammatory Agents - therapeutic use CD4 Lymphocyte Count CD8-Positive T-Lymphocytes - cytology Enzyme-Linked Immunosorbent Assay Female Follow-Up Studies Giant Cell Arteritis - drug therapy Giant Cell Arteritis - immunology Humans Male Middle Aged Polymyalgia Rheumatica - drug therapy Polymyalgia Rheumatica - immunology Prednisolone - therapeutic use Prospective Studies Receptors, Interleukin-2 - analysis Recurrence Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!